Annual report pursuant to Section 13 and 15(d)

CASH AND CASH EQUIVALENTS

v3.23.1
CASH AND CASH EQUIVALENTS
 12 Months Ended
Mar. 31, 2022
Cash and Cash Equivalents [Abstract]  
CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS
March 31, 2022 March 31, 2021
(recast) (recast)
Current accounts with brokers $ 70,830  $ 37,324 
Current accounts with commercial banks 69,982  61,203 
Current account with National Bank (Kazakhstan) 42,517  36,726 
Securities purchased under reverse repurchase agreements 19,725  11,917 
Petty cash in bank vault and on hand 18,467  14,916 
Accounts with stock exchange 2,828  5,873 
Current account with Central Depository (Kazakhstan) 314  58 
Total cash and cash equivalents $ 224,663  $ 168,017 
As of March 31, 2022 and 2021, with the exception of funds deposited with a bank in the United States which may qualify for FDIC insurance up to $250,000, cash and cash equivalents were not insured. As of March 31, 2022 and 2021, the cash and cash equivalents balance included collateralized securities received under reverse repurchase agreements on the terms presented below:
March 31, 2022 (recast)
Interest rates and remaining contractual maturity of the agreements
Average
Interest rate		 Up to 30
days		 30-90
days		 Total
Securities purchased under reverse repurchase agreements
Corporate equity 16.90  % $ 152  $ —  $ 152 
US sovereign debt 16.38  % 9,952  —  9,952 
Non-US sovereign debt 12.45  % 9,565  —  9,565 
Corporate debt 11.88  % 56  —  56 
Total $ 19,725  $ —  $ 19,725 
March 31, 2021 (recast)
Interest rates and remaining contractual maturity of the agreements
Average
Interest rate		 Up to 30
days		 30-90
days		 Total
Securities purchased under reverse repurchase agreements
Non-US sovereign debt 0.88  % $ 1,785  $ —  $ 1,785 
Corporate debt 10.15  % 8,460  —  8,460 
Corporate equity 13.09  % 110  —  110 
US sovereign debt 0.50  % 1,562  —  1,562 
Total $ 11,917  $ —  $ 11,917 
The securities received by the Company as collateral under reverse repurchase agreements are liquid trading securities with market quotes and significant trading volume. The fair value of collateral received by the Company under reverse repurchase agreements as of March 31, 2022 and 2021, was $19,691 and $12,123 respectively.